PFIZER · Healthcare
The board meets on 3 Nov 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹575 cr | ₹540 cr | ₹547 cr | ₹563 cr | ₹589 cr | ₹538 cr | ₹592 cr | ₹603 cr | ₹642 cr | ₹645 cr | ₹629 cr | ₹653 cr |
| YoY | — | — | — | +6% | +2% | −0% | +8% | +7% | +9% | +20% | +6% | +8% |
| EBITDA margin | 31.8% | 28.3% | 34.6% | 31.4% | 32.1% | 27.1% | 38.5% | 34.8% | 35.8% | 35.3% | 37.5% | 38.0% |
| Other income, % of PBT | 18% | 25% | 31% | 21% | 20% | 25% | 51% | 26% | 16% | −10% | 19% | 16% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 26% | 26% | 27% | 26% | 26% | 26% | 22% | 26% | 26% | 26% | 26% | 26% |
| Net profit | ₹149 cr | ₹130 cr | ₹179 cr | ₹151 cr | ₹158 cr | ₹128 cr | ₹331 cr | ₹192 cr | ₹189 cr | ₹142 cr | ₹200 cr | ₹204 cr |
| YoY | — | — | — | +61% | +6% | −2% | +85% | +27% | +20% | +11% | −40% | +6% |
| Core profit YoY | — | — | — | +73% | +4% | −2% | +24% | +20% | +24% | +64% | +5% | +20% |
| EPS | ₹32.56 | ₹28.41 | ₹39.10 | ₹32.94 | ₹34.61 | ₹27.89 | ₹72.34 | ₹41.91 | ₹41.32 | ₹31.00 | ₹43.68 | ₹44.70 |
| Flags | · | · | 1 | ✓ | ✓ | ✓ | 2 | ✓ | ✓ | ✓ | ✓ | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.